Ended Therapeutic use (Phase IV) Patient presenting to the neuroradiological emergency room with an ischemic stroke and requiring interventional neuroradiology for stroke. Only patients with significant gastric contents on ultrasound (stomach is full: antral area >340mm²) according to a measurement taken before the start of the procedure in the supine position will be randomized in the study.

Impact on gastric emptying measured by antral gastric ultrasound of erythromycin administration in stroke patients with indication for mechanical thrombectomy.

EU CTIS ID: 2023-508120-35-00

What this study is testing

To evaluate the efficacy of erythromycin IVSE on decreasing antral surface area by emergency mechanical thrombectomy procedure in patients with ischemic stroke.

  • Therapeutic use (Phase IV)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Major patients with ischemic stroke
  • Requiring emergency interventional neuroradiology for mechanical thrombectomy for stroke, regardless of anesthetic procedure (AG or AL)
  • Informed consent obtained from the patient/relative or following an emergency procedure.
  • Being affiliated to a health insurance plan

You likely can't join if

  • Pregnant woman
  • Deprived of liberty or under tutelage
  • Allergy to macrolides, curares (succinylcholine, rocuronium)
  • Nasogastric tube placement prior to interventional radiology admission
  • Patient already intubated on arrival
  • Minor or protected adult
See the full eligibility criteria
Who can join
  • Major patients with ischemic stroke
  • Requiring emergency interventional neuroradiology for mechanical thrombectomy for stroke, regardless of anesthetic procedure (AG or AL)
  • Informed consent obtained from the patient/relative or following an emergency procedure.
  • Being affiliated to a health insurance plan
What rules you out
  • Pregnant woman
  • Deprived of liberty or under tutelage
  • Allergy to macrolides, curares (succinylcholine, rocuronium)
  • Nasogastric tube placement prior to interventional radiology admission
  • Patient already intubated on arrival
  • Minor or protected adult
  • Contraindication to erythromycin administration: known allergy, hepatic porphyria
  • Scheduled return trip, within less than 24 hours, to a neurology department outside Hôpital Foch

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.